Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001640334-21-000425
Filing Date
2021-02-24
Accepted
2021-02-23 21:04:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A lexx_sc13da.htm SC 13D/A 60099
  Complete submission text file 0001640334-21-000425.txt   61488
Mailing Address 1924 BIRKDALE AVE KELOWNA A1 V1P1R7
Business Address
BUNKA CHRISTOPHER (Filed by) CIK: 0001103780 (see all company filings)

Type: SC 13D/A

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Subject) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: SC 13D/A | Act: 34 | File No.: 005-85256 | Film No.: 21668157
SIC: 2834 Pharmaceutical Preparations